Association of NGS mutational pattern with immune checkpoint inhibitor clinical benefit in solid tumors (original) (raw)

paper cover icon

Association of NGS mutational pattern with immune checkpoint inhibitor clinical benefit in solid tumors

Journal of Clinical Oncology

Claudia HuettnerClaudia Huettner

Abstract

e24274Background: Immune checkpoint inhibitors (CPIs) induce prolonged tumor responses in a minority of patients with solid tumors including those with MSI-high, melanoma and NSCLC. Established pre...

Claudia Huettner hasn't uploaded this paper.

Let Claudia know you want this paper to be uploaded.

Ask for this paper to be uploaded.